ArticleMolecular medicine reports2019

PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis.

Jie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.